BRISTOL-MYERS SQUIBB, S.A. secures contract for Pharmaceutical products - Framework Agreement for the supply of medicines without competition for the hospitals of the Cantabrian Health Service (Active ingredients Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod)

Spain, Sept. 28 -- Spain based BRISTOL-MYERS SQUIBB, S.A. has secured contract from Servicio Cantabro de Salud for Pharmaceutical products - Framework Agreement for the supply of medicines without competition for the hospitals of the Cantabrian Health Service (Active ingredients Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod) . The value of the contract is worth 402334 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....